The posters can be accessed through the “Supporting Publications” tab on the “Our Approach” section of the Zentalis website at the time of each presentation’s starting session.

One poster demonstrating cell-free DNA molecular ... 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially ...

The posters can be accessed through the “Supporting Publications” tab on the ... thereby resulting in the accumulation of DNA damage and leading to mitotic catastrophe and cancer cell death. Zentalis ...

BOSTON and LONDON, March 06, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq ... hypersomnia (IH), will be presented in a poster session at the American Academy of Neurology ...

The posters can be accessed through the “Supporting ... leading to mitotic catastrophe and cancer cell death. Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company ...

Three additional posters highlighting the potential for broad therapeutic applications of azenosertib as both a single agent and combination therapy as shown in preclinical models SAN DIEGO, March 25, ...

The posters can be accessed through the “Supporting Publications” tab on the “Our Approach” section of the Zentalis website at the time of each presentation’s starting session. Azenosertib is a novel, ...